Inhibiting extracellular QSOX1 activity by antibody blockade significantly disrupted the ECM structure, thereby reducing cancer cell adhesion, invasion, or migration in vitro [9,15,16] and suppressing tumor growth and metastasis in vivo [17]. The gene discussed is QSOX1; the disease is neoplasm.